C M Adeyeye
Overview
    Explore the profile of C M Adeyeye including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              13
            
            
              Citations
              45
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Ebube N, Adeyeye C
  
  
    Int J Pharm
    . 2000 Feb;
          196(1):27-35.
    
    PMID: 10675705
  
  
          The utility of artificial neural networks (ANNs) as a preformulation tool to determine the physicochemical properties of amorphous polymers such as the hydration characteristics, glass transition temperatures and rheological properties...
      
2.
        
    
    Sabnis S, Adeyeye C
  
  
    Drug Dev Ind Pharm
    . 1999 Mar;
          25(2):187-96.
    
    PMID: 10065352
  
  
          Directly compressible controlled-release (CR) theophylline tablet formulations with a non-zero-order drug release were prepared using various grades of Methocels. These tablet formulations were employed in the individualization of therapy with...
      
3.
        
    
    Janjikhel R, Adeyeye C
  
  
    Pharm Dev Technol
    . 1999 Feb;
          4(1):9-17.
    
    PMID: 10027208
  
  
          The purpose of this research was to evaluate the stereospecific interaction of ibuprofen with chiral excipients such as hydroxypropyl-beta-cyclodextrin (HPCD), tartaric acid, sucrose, hydroxypropylmethylcellulose (HPMC), methylcellulose (MC), and a nonchiral...
      
4.
        
    
    Lewis L, Boni R, Adeyeye C
  
  
    J Microencapsul
    . 1998 Sep;
          15(5):555-67.
    
    PMID: 9743912
  
  
          The major challenge in liquid sustained-release oral suspensions is to minimize drug diffusion into the suspending medium and to retain the original properties of the microparticles during storage. Diclofenac wax...
      
5.
        
    
    Lewis L, Boni R, Adeyeye C
  
  
    J Microencapsul
    . 1998 Jun;
          15(3):283-98.
    
    PMID: 9608393
  
  
          This investigation involved the evaluation of the emulsifier blend effect on the development of sustained release diclofenac microspheres intended for use in a suspension formulation. The microspheres were prepared using...
      
6.
        
    
    Adeyeye C, Chen F
  
  
    Pharm Res
    . 1998 Feb;
          14(12):1811-6.
    
    PMID: 9453073
  
  
          Purpose: The aim of the study is to evaluate stereoselective in vivo disposition of suspensions of conventional and wax-matrix sustained release ibuprofen microspheres in rats. Methods: Male wistar rats were...
      
7.
        
    
    Janjikhel R, Adeyeye C
  
  
    J Microencapsul
    . 1997 Jul;
          14(4):409-26.
    
    PMID: 9229341
  
  
          Ibuprofen microspheres were prepared from the racemate, (+)-S and (-)-R enantiomers using waxes such as ceresine and glyceryl stearate and stereospecifically characterized. The method of preparation of the microspheres was...
      
8.
        
    
    Adeyeye C, Price J
  
  
    J Microencapsul
    . 1997 May;
          14(3):357-77.
    
    PMID: 9147285
  
  
          Chemical stability studies of suspensions of ibuprofen powder and ibuprofen-wax microspheres were performed using an accelerated stability protocol with a modified high performance liquid chromatography (HPLC) procedure. The variables considered...
      
9.
        
    
    Wipf P, Li W, Adeyeye C, Rusnak J, Lazo J
  
  
    Bioorg Med Chem
    . 1996 Oct;
          4(10):1585-96.
    
    PMID: 8931928
  
  
          N4-Dipeptidyl slow-release forms of the anticancer drug ara-C were prepared by acylation of the lithiated nucleotide with 4,4-dialkyloxazolinones. An azapeptide prodrug of ara-C was obtained by condensation of an amino...
      
10.
        
    
    Adeyeye C, BRICKER J, Vilivalam V, Smith W
  
  
    Pharm Res
    . 1996 May;
          13(5):784-93.
    
    PMID: 8860438
  
  
          Purpose: The study examined the gastrointestinal (GIT) toxicity effects of suspensions of encapsulated and unencapsulated ibuprofen in male Wistar rats. Methods: Rats were randomly divided into four experimental groups and...